A panel of 12 antibodies, selected to elucidate the cell state, breast cancer epithelial cells, stromal compartment, tissue architecture, and immune infiltrate of HER2+ breast cancers (Table 1), were conjugated to a unique DS. This evidence concerns the gene ERBB2 and breast cancer.